American CryoStem Corporation Announces Name Change to ACS Global, Inc.
15 Giugno 2011 - 3:00PM
Marketwired
American CryoStem Corporation (PINKSHEETS: AMCY) announced today
that at the open of business June 15, 2011, the name change of
American CryoStem Corporation to ACS Global, Inc. will take effect.
The Company will retain its current symbol AMCY.PK.
Mr. Anthony Dudzinski, CEO, stated, "We are excited to complete
this name change as the final step in our transaction with R &
A Productions, Inc. ACS Global will continue to explore
opportunities globally to secure and expand its position within the
stem cell and regenerative medicine industry."
About ACS Global, Inc.: ACS Global, Inc.
is the controlling shareholder of American CryoStem Corporation,
and develops new technologies internally and through strategic
relationships in the rapidly developing regenerative medicine and
stem cell industry.
The Private Securities Litigation Reform Act of 1995 provides a
"safe harbor" for forward-looking statements. Certain of the
statements contained herein, which are not historical facts, are
forward-looking statements with respect to events, the occurrence
of which involve risks and uncertainties. These forward-looking
statements may be impacted, either positively or negatively, by
various factors. Information concerning potential factors that
could affect the Company is detailed from time to time in the
Company's reports filed with the Securities and Exchange
Commission.
For More Information, contact: Investor Relations American
CryoStem Corporation 188 East Bergen Place, Suite 204 Red Bank, NJ
07701 Phone:732-747-1007 Fax: 732-747-7782
www.americancryostem.com
Grafico Azioni ACS Global (CE) (USOTC:AMCY)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni ACS Global (CE) (USOTC:AMCY)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a ACS Global Inc (CE) (OTCMarkets): 0 articoli recenti
Più American CryoStem Articoli Notizie